CAAS Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,500
Closed -$189K 569
2024
Q4
$189K Buy
+1,500
New +$223K 0.03% 254
2024
Q3
Sell
-2,600
Closed -$346K 463
2024
Q2
$346K Sell
2,600
-700
-21% -$84.3K 0.11% 125
2024
Q1
$347K Buy
3,300
+1,300
+65% +$117K 0.03% 343
2023
Q4
$151K Buy
+2,000
New +$127K 0.02% 366
2023
Q3
Sell
-5,500
Closed -$448K 807
2023
Q2
$448K Buy
+5,500
New +$392K 0.03% 403

Other funds holding THC

CAAS Capital Management's THC Position: Q1 2025 in Review

CAAS Capital Management sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 780 shares — an estimated $98.5K sold.

CAAS Capital Management first reported a position in THC in Q1 2021 and held it in 2 quarters. The position peaked at $5.18M in Q1 2021. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • CAAS Capital Management reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • CAAS Capital Management sold 780 Tenet Healthcare shares in Q1 2025, an estimated $98.5K.
  • CAAS Capital Management first reported a position in Tenet Healthcare in Q1 2021 and held it in 2 quarters.
  • CAAS Capital Management's Tenet Healthcare position peaked at $5.18M in Q1 2021.
  • 566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.